These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Has Medicare neglected DME for too long? Region IV voted 'yes'. Lord C; Bedford J; Fischer D MPS; 1980 Aug; 11(8):74-7, 83-7, 91. PubMed ID: 10297924 [No Abstract] [Full Text] [Related]
3. Lowest charge level for medical services, supplies, and equipment: final regulations. Fed Regist; 1978 Jul; 43(144):32294-301. PubMed ID: 10297137 [No Abstract] [Full Text] [Related]
4. Industry representatives await HHS' new capital reimbursement policy. Baldwin MF Mod Healthc; 1985 Nov; 15(23):29. PubMed ID: 10300439 [No Abstract] [Full Text] [Related]
5. Retroactivity and administrative rulemaking. Luneburg WV Duke Law J; 1991 Feb; (1):106-65. PubMed ID: 10114415 [No Abstract] [Full Text] [Related]
6. Collection and compromise of Medicare overpayment claims from providers, physicians, and other suppliers of services: final rule. Fed Regist; 1978 Dec; 43(245):59380-2. PubMed ID: 10297321 [No Abstract] [Full Text] [Related]
7. Federal health insurance for the aged and disabled--coverage of dialysis supplies, equipment, and support services: final rule. Fed Regist; 1978 Oct; 43(206):49719-23. PubMed ID: 10297256 [No Abstract] [Full Text] [Related]
9. Why is HHS-HCFA losing in the courts? Hedlund CT Healthspan; 1989 Jan; 6(1):9-13. PubMed ID: 10303113 [No Abstract] [Full Text] [Related]
10. Challenges to the Medicare reimbursement appeal methodology under PPS: a review. Cohen I Health Law Vigil; 1986 Jun; 9(12):15-7. PubMed ID: 10300784 [No Abstract] [Full Text] [Related]
11. Commentary on payment and reimbursement issues affecting the marketing of drugs, medical devices, and biologics, with emphasis on the anti-kickback statute and Stark II. Reiss JB Food Drug Law J; 1997; 52(1):99-108. PubMed ID: 10346713 [No Abstract] [Full Text] [Related]
12. Principles of reimbursement for provider costs and for services by hospital-based physicians; direct apportionment of malpractice costs to Medicare: final rule. Fed Regist; 1979 Jun; 44(107):31641-2. PubMed ID: 10297453 [No Abstract] [Full Text] [Related]
13. Pharmaceutical manufacturers seek OIG comfort. Becker S Health Care Law Mon; 2002 Aug; ():3-6. PubMed ID: 12420396 [No Abstract] [Full Text] [Related]
14. Medicare program; limiting reimbursement for provider costs and for services by hospital-based physicians: final regulation. Fed Regist; 1979 Jun; 44(107):31802-5. PubMed ID: 10297454 [No Abstract] [Full Text] [Related]
15. Medicare program; reimbursement for costs of approved internship and residency programs: proposed rule. Fed Regist; 1979 Aug; 44(156):47117-8. PubMed ID: 10297529 [No Abstract] [Full Text] [Related]
16. HHS Inspector General sets lead for oversight accountability of providers. Lee FC Bus Health; 1986 Apr; 3(5):51. PubMed ID: 10300636 [No Abstract] [Full Text] [Related]
17. Scrimmage. The DME play-by-play. Henry T Home Health J; 1986 Dec; 7(12):3, 10. PubMed ID: 10301190 [No Abstract] [Full Text] [Related]
18. After the PRRB: HCFA and judicial review. Malloy JW Top Health Care Financ; 1979; 5(3):95-102. PubMed ID: 371081 [No Abstract] [Full Text] [Related]
19. How to prepare and present an appeal to the PRRB. Memel SL; Tichon MJ Top Health Care Financ; 1979; 5(3):63-73. PubMed ID: 371076 [No Abstract] [Full Text] [Related]